Advances in Liver Disease 2026: A Year in Review

Saturday, December 5, 2026, 7:30 AM - 3:00 PM, Hilton Philadelphia City Avenue, Philadelphia, PA


AMA PRA Category 1 Credits™ (5.75 hours), ABS CC (5.75 hours), ACPE Contact Hour(s) (5.75 hours), ANCC Contact Hour(s) (5.75 hours), Non-Physician Attendance (5.75 hours), Nursing Pharmacology Credit (3.25 hours), PA Patient Safety and Risk Credit (1.00 hours)

This annual symposium will introduce the latest developments in liver disease as presented by experts in the field of Hepatology.

Liver disease can be a complex issue and patient problems are diverse, necessitating a team approach with differing expertise and skills. Attendees will be able to participate in the interactive panel discussions throughout the day.

Note: This Symposium will occur post AASLD Annual Meeting and bring the highlights of this event to Philadelphia.

Keynote: Marlyn Mayo MD

Dr. Marlyn Mayo earned her MD from Baylor College of Medicine, completed internal medicine training at UC Irvine, and a gastroenterology/hepatology fellowship at UT Southwestern. Dr. Mayo developed an interest in primary biliary cirrhosis (PBC) through her focus on autoimmune diseases and mentorship during residency. At UT Southwestern, she contributed to a major PBC clinical trial and conducted both patient-based and laboratory research on its causes.

She later collaborated on research in intrahepatic cholestasis of pregnancy (ICP), a condition related to PBC, helping advance genetic insights that may inform PBC research. Her work expanded to other pregnancy-related liver diseases.

Currently, her research centers on the pathogenesis of autoimmune liver diseases, including mechanisms of bile duct injury in PBC and cryoglobulin development in hepatitis C. She studies immune cell signaling and leads clinical trials investigating new PBC treatments.

The Liver Meeting® and AASLD are registered trademarks of the American Association for the Study of Liver Diseases (AASLD). All content is derived from presentations and similar offerings made available at The Liver Meeting® 2026 and is presented with permission of AASLD.

Successful Completion
To successfully complete this activity, the required evaluation must be completed no later than Saturday, December 26, 2026. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.

1. Employ current guidelines and treatment strategies for managing viral hepatitis, MASLD, cholestatic and alcoholic liver diseases.
2. Acquire updates in the field of advanced liver disease, liver cancer and liver transplantation.
3. Review the presentation patterns of liver injury from drugs and herbal and dietary supplements.
4. Explain the pathophysiology and complications of hemostatic alterations in cirrhosis and portal hypertension and the management approach to miscellaneous disorders of the liver.
5. Understand the ways in which artificial intelligence (AI) is transforming the field of hepatology.”

Non-Jefferson	Fee
Physician Nurse/Nurse Practitioner Pharmacist Physician Assistant Allied Health Professional  Residents/Fellows Industry Professional	$100  $50 $50 $50 $50 $0 $300
Jefferson	Fee
Physician Nurse/Nurse Practitioner Pharmacist Physician Assistant Allied Health Professional Resident/Fellow	$0 $0 $0 $0 $0 $0

 

 

In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: This educational activity is designated for a maximum of 5.75 AMA PRA Category 1 Credits ^TM . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses: This activity awards 5.75 nursing contact hours.

Pharmacists: This knowledge-based continuing education is designated for 5.75 credit contact hours of continuing education credit.  JA4008236-0000-26-020-L01-P
Credits will be uploaded to CPE Monitor within 60 days following the completion of the activity. This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner's e-profile in CPE Monitor.

Other Healthcare Professionals: This educational activity is designated for 5.75 AMA PRA Category 1 Credit ^TM. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Pharmacology Credit: This educational activity offers 3.25 nursing pharmacology credit. Qualifying sessions are noted on the agenda.

PA Patient Safety and Risk Credit: This education activity offers 1.00 PA Patient Safety and Risk credit. Qualifying sessions are noted on the agenda.

American Board of Certification for Gastroenterology Nurses (ABCGN): This educational activity is pending approval by the American Board of Certification for Gastroenterology Nurses (ABCGN).

Cancellation Policy
Requests for refunds must be submitted in writing and received in the Office of CPD two weeks prior to the start date of the course. There will be no refunds after this period.* Cancellations notified before the two week time frame will incur a 25% administration fee (with a minimum of $20). Registrants who fail to attend the conference are responsible for the entire fee. All refunds will be processed after the conference. The University reserves the right to cancel or postpone this course due to unforeseen circumstances. In the event of cancellation or postponement, the University will refund registration fees, but is not responsible for related costs or expenses to participants, including cancellation fees assessed by hotels, airlines or travel agencies. Registration fees will be refunded less a 15% administration fee to international conference registrants who are unable to secure a travel visa. Registrants must provide proof of visa denial. Email [email protected] - please include the activity name in the subject line.

 Jefferson Release Policy
Jefferson may record/livestream/photograph this educational activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive the right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt, and distribute at any time in any manner or medium.

Jefferson HIPAA Policy
As an attendee of this educational activity hosted by Thomas Jefferson University, Jefferson University Physicians, and Thomas Jefferson University Hospitals, Inc. (collectively 'Jefferson'), you may gain access to certain proprietary information ('Confidential Information'), including Protected Health Information ('PHI').

By participating in this educational activity, you agree to maintain the confidentiality of all Confidential Information, including all PHI, obtained from any source. You also agree to take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the educational activity. Further, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information may result in possible legal action against you by Jefferson whose confidentiality is breached.

Photography and Recording
Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be asked to vacate the activity. No credits or refund will be issued.

Copyright
All rights reserved – Thomas Jefferson University. No part of this program may be used, reproduced, or shared in any manner whatsoever without express written permission, except in the case of brief quotations embodied in articles or reviews.

Mitigation of Relevant Financial Relationships

Thomas Jefferson University adheres to the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.

All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity. Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.

Off-Label/Investigational Use
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.

AI Use in Accredited Content
All faculty, presenters, and authors participating in Thomas Jefferson University–sponsored events must disclose any use of AI in creating or editing content. Disclosures should specify the AI tool’s name, version, and date of use, and briefly describe how it supported the work—for example, drafting, data analysis, or assessment development. They must also identify the model or source, state that all outputs were reviewed and verified by a human (including who conducted the review and how), and indicate whether any prompts or outputs were stored externally.

Saturday, December 5, 2026

Exhibitors are invited to participate in this premier annual conference dedicated to showcasing the latest developments in liver disease, as presented by leading experts in Hepatology.

This activity brings together a multidisciplinary audience, reflecting the complexity of liver disease and the diverse patient challenges that require a coordinated, team-based approach.

This conference offers exhibitors a valuable opportunity to connect with healthcare professionals, highlight innovations, and demonstrate solutions that support comprehensive, collaborative patient care.

Application Deadline
Applications for exhibiting will be accepted through November 20, 2026. After November 20, 2026, applications may be accepted on a case by case basis.

Exhibitor Rules

• Exhibitor is not providing commercial support for this activity; they are purchasing exhibit space only.

• All exhibits must be tabletop or portable in nature.

• Exhibitor activities are restricted to the designated space at the conference. Distribution of educational/promotional materials by the exhibitors is limited to their booth space in the exhibit area. It is not permitted anywhere else in the hall, conference meeting space, or at the entrances to the conference meeting space.

• Exhibits are intended for informational purposes only; products should not be sold onsite.

• Photography by exhibitors that include images of the conference or its attendees is prohibited.

• The purpose of the exhibit is to support attendee education through product and service displays and demonstrations. Exhibitor personnel may observe scientific sessions but may not participate in or record them on behalf of their company.

• Thomas Jefferson University is not responsible for the security of exhibitors’ materials. Exhibitors are advised not to leave valuables (e.g., laptops, cell phones) unattended at any time.

Cancellation by Conference Organizers
If the conference is cancelled, the organizers are not responsible for any airfare, hotel, or other costs incurred by exhibitors. The full exhibit fee paid by the company will be refunded.

Exhibitor Refund Request
Requests for exhibitor fee refunds must be submitted in writing and received by the Office of Continuing Professional Development (OCPD) at least one month before the conference start date. Cancellations received before this deadline will incur a 10% cancellation fee. No refunds will be issued after this period. All refunds will be processed after the conference.

Exhibitors who do not attend the conference will not receive a refund. Send refund request to [email protected]. Include conference name in the subject line.

Exhibit at this Event